Chemical Structure (Gabapentin 01)
Gabapentin
Product Images NDC 50090-5322
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-5322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin 02)
This is a chart that appears to be measuring pain scores over an eight-week period. The x-axis displays the weeks from baseline to week eight, and the y-axis represents the pain score from 0 to 10. The chart compares the pain scores of a placebo group to the pain scores of a group taking a set dose of gabapentin. The study measures the mean pain score for each group.*
Figure 2 (Gabapentin 03)
Figure 3 (Gabapentin 04)
This table appears to show percentages and statistical significance levels (p-values) for two different studies involving PBO and GBP. The first study has a result of 0%, while the second study has percentages of 70%, 80%, 90%, and 100%, with increasing levels of statistical significance denoted by asterisks. The specific nature of these percentages or what the acronyms PBO and GBP stand for is not discernible from this text.*
Figure 4 (Gabapentin 05)
Label Image (Lbl500905322)
This is a nutritional supplement called Gharsentin in the form of 90 capsules. Each capsule contains 480 mg of the supplement. The product number is 5861-0. The label indicates that it should be stored at 7 degrees Celsius.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
